NanoLogix Gets European Patent, Draws NASA Interest
HUBBARD, Ohio -- NanoLogix Inc. announced this morning that the European Patent Office has informed its London and U.S. patent law firms that its European application for the NanoLogix BNP sandwiched-membrane Petri based detection technology has received an allowance for grant under the European Patent Convention. NanoLogix is an innovator in the rapid detection of viable bacteria, and identification and determination of antibiotic resistance/sensitivity of those bacteria,
The patent will cover up to 38 member countries, dependent upon NanoLogix’s election, and significantly enhances the NanoLogix patent portfolio, the company reported. The BNP technology received patent grants in 2013 in both Japan and Russia and its patent is pending in the United States.
NanoLogix also reports that it has supplied NASA with a number of Petri and BNP FlatPacks for the space agency’s use following a visit by NASA representatives to the company’s booth at the American Society for Microbiology‘s annual meeting in late May. The NASA officials commented that the NanoLogix Petri plates vacuum packed in nitrogen-charged FlatPacks were exactly what they had been looking for and intended to send them to the International Space Station. The company is currently awaiting further information from NASA.
U.S. Rep. Tim Ryan, D-13 Ohio, and his staff also are working with the company to explore potential federal uses for its technologies. NanoLogix management will travel to Washington, D.C. this month for meetings with the congressman and his staff.
In August, NanoLogix will exhibit at the BioOhio BioScience Expo and Showcase to be held Aug. 5 in Aurora.
Pictured: Bret Barnhizer, NanoLogix CEO.
Published by The Business Journal, Youngstown, Ohio.
CLICK HERE to subscribe to our twice-monthly print edition and to our free daily email headlines.